≥99% HPLCPre-filled pen

Prostamax

Name: Prostamax
Brand: Dripfy
Availability: InStock

What it is?

Prostamax is a prostate-targeted peptide bioregulator positioned to support prostate tissue function and urogenital health. It is studied within frameworks focused on cellular function normalisation and tissue maintenance endpoints.

Dripfy Advantage

Organ-specific regulation: Designed for prostate-tissue support, aligning with tissue-specific bioregulator methodology.
Protein synthesis modulation: Positioned to influence protein synthesis in prostate tissue cells, supporting structural and functional integrity.
Cellular function normalisation: Associated with pathways that support normalisation of prostate cellular activity markers.
Male wellness integration: Often positioned within broader male health protocols where endocrine, urogenital, and ageing endpoints intersect.

Clinical Applications & Therapeutic Potential

Prostate function endpoints: Potential support for healthy prostate function markers and urogenital wellbeing parameters.
Prostate size and maintenance markers: Positioned for maintaining normal prostate tissue dynamics and structural balance endpoints (context-dependent).
Urogenital health support: Potential contribution to male urogenital health frameworks through tissue-level regulatory signalling.
Age-related prostate wellness: Relevant to healthspan protocols where prostate resilience and long-term maintenance are priorities.

Composition & Formulation

Class: Prostate-specific bioregulatory peptide (prostate bioregulator class)
Format: Ready-to-use pre-filled pen

€413

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

Prostamax

Investigational prostate-directed peptide bioregulator (Khavinson-type) · Pre-filled pen

D· Preliminary evidence

Prostamax is a peptide bioregulator proposed to act on prostate-tissue cells by influencing protein-synthesis and cellular-function signalling. The studied idea is tissue-specific support of normal prostate cell activity, but the evidence base is largely preclinical and from a limited research tradition. It has not been established as a treatment for prostate conditions in humans.

Studied use areas

Prostate-tissue maintenance signalling (research interest)
Protein-synthesis regulation in prostate cells
Normalisation of prostate cellular-activity markers (investigational)
Urogenital and male healthy-ageing frameworks (exploratory)

Safety & status

Investigational bioregulator without established human safety data; physician supervision required
Not approved as a medicine by EMA or MHRA
Urinary or prostate symptoms require clinical evaluation to exclude serious conditions, not self-treatment

⚕ Clinical note: This is educational information only and not medical advice. Prostamax is investigational; any use should be individualised and determined by a treating physician under appropriate supervision.

Evidence: Grade D — investigational; mechanistic and small-model data only, with no robust independent human trials. · References: Peer-reviewed peptide-bioregulator (Khavinson) research literature; Urology and prostate-physiology reviews; EMA/MHRA guidance on unlicensed investigational substances